Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI055844-02
Application #
6755064
Study Section
Special Emphasis Panel (ZRG1-VACC (02))
Program Officer
Zou, Lanling
Project Start
2003-07-01
Project End
2007-12-31
Budget Start
2004-01-01
Budget End
2004-12-31
Support Year
2
Fiscal Year
2004
Total Cost
$523,755
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Genetics
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Sofer-Podesta, Carolina; Ang, John; Hackett, Neil R et al. (2009) Adenovirus-mediated delivery of an anti-V antigen monoclonal antibody protects mice against a lethal Yersinia pestis challenge. Infect Immun 77:1561-8
De, Bishnu P; Hackett, Neil R; Crystal, Ronald G et al. (2008) Rapid/sustained anti-anthrax passive immunity mediated by co-administration of Ad/AAV. Mol Ther 16:203-9
Chiuchiolo, Maria J; Boyer, Julie L; Krause, Anja et al. (2006) Protective immunity against respiratory tract challenge with Yersinia pestis in mice immunized with an adenovirus-based vaccine vector expressing V antigen. J Infect Dis 194:1249-57
Boyer, Julie L; Kobinger, Gary; Wilson, James M et al. (2005) Adenovirus-based genetic vaccines for biodefense. Hum Gene Ther 16:157-68